Evidence map›Paper›PMID 40365561›Full record

ArticleFrontiers in plant science2025

Assessing

Sampath Kasthurirengan, Yan Hong, Srinivasan Ramachandran

Abstract read
In one paragraph

Article in Frontiers in plant science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sampath KasthurirenganTemasek Lifesciences Laboratory, National University of Singapore, Singapore, Singapore.
Yan HongJOil (S) Pte Ltd., National University of Singapore, Singapore, Singapore.
Srinivasan RamachandranTemasek Lifesciences Laboratory, National University of Singapore, Singapore, Singapore.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Pollen plays a critical role in transgene flow between non-transgenic plants, influencing gene dispersal and environmental risk considerations. Jatropha ( Methods: Pollen viability of X8#34 transgenic and non-transgenic Jatropha was assessed using various staining techniques. An optimized double-staining technique with Fluorescein Diacetate (FDA) and Propidium Iodide (PI) was developed, effectively differentiated viable pollen (green fluorescence) from non-viable (red fluorescence). The effects of temperatures (18°C, 28°C, 30°C 35°C, 40°C and 45°C) and UV-B irradiation (3 to 15 W/m2) on pollen viability ware examined. Additionally, viability was assessed under field-relevant conditions, including sunny and cloudy/shady atmospheric environments. Results: A significant reduction in pollen viability was observed under extreme temperature and UV-B stress. Among different temperatures tested, high temperatures (35°C, 40°C and 45°C) led to a significant decline in pollen viability, with notable differences emerging from 15 min of incubation. Additionally, exposure to high-intensity UV-B irradiation (12 W/m2 and 15 W/m2) significantly reduced the pollen viability. Under a field relevant sunny condition, viability dropped to 19% in transgenic and 16% in non-transgenic after 45 min incubation and complete loss was recorded in 90 min in both genotypes. In cloudy/shady conditions, over 97% of pollen lost viability in 240 min incubation. Statistical analysis confirmed no significant difference is pollen viability between X8#34 and non-transgenic Jatropha across all tested conditions. Discussion: This study provides the first comprehensive assessment of pollen viability in transgenic and non-transgenic Jatropha. The findings highlight the significant influence of environmental factors, particularly temperature and UV-B exposure, on pollen longevity. The optimized double staining technique (FDA + PI) provides a reliable method for assessing pollen viability and may be useful in environmental risk evaluations of transgenic Jatropha. Given the rapid decline in pollen viability under field-relevant conditions, the likelihood of transgene flow via pollen appears limited.

Indexed as

FDA+PI combinationJatropha pollennon-transgenicpollen viabilityX8#34 transgenic

Identifiers

PMID40365561
PMCPMC12069449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.